InvestorsHub Logo
Followers 29
Posts 2503
Boards Moderated 0
Alias Born 04/09/2010

Re: None

Wednesday, 10/14/2015 11:19:30 AM

Wednesday, October 14, 2015 11:19:30 AM

Post# of 23979
$AVXLD Anavex Awarded Grant From The Michael J. Fox Foundation for Parkinson’s Research - See more at: http://globenewswire.com/news-release/2015/08/10/759225/0/en/Anavex-Awarded-Grant-From-The-Michael-J-Fox-Foundation-for-Parkinson-s-Research.html#sthash.rG3Tzl4H.dpuf

NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop ANAVEX 2-73 for the treatment of Parkinson’s disease.


The MJFF grant is expected to fully fund a preclinical study on the effect of ANAVEX 2-73 in a Parkinson’s disease animal model, which seeks to provide a solid dataset that will justify moving forward to clinical development in Parkinson’s. The study may also provide further evidence for the involvement of sigma-1 receptors in potentially disease-modifying therapies for Parkinson’s disease.
- See more at: http://globenewswire.com/news-release/2015/08/10/759225/0/en/Anavex-Awarded-Grant-From-The-Michael-J-Fox-Foundation-for-Parkinson-s-Research.html#sthash.rG3Tzl4H.dpuf
http://bit.ly/1VSxs5v

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.